Polaris Wealth Advisory Group, LLC Abb Vie Inc. Transaction History

Polaris Wealth Advisory Group, LLC

$1.3 Billion
Q3 2023

A detailed history of Polaris Wealth Advisory Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Polaris Wealth Advisory Group, LLC holds 212,188 shares of ABBV stock, worth $35.5 Million. This represents 2.43% of its overall portfolio holdings.

Number of Shares

212,188

Previous 211,651 0.25%

Holding current value

$35.5 Million

Previous $28.5 Million 10.92%

% of portfolio

2.43%

Previous 2.2%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	BUY	$133.59 - $154.65 $71,737 - $83,047	537 Added 0.25%	212,188 $31.6 Million
Q2 2023 Aug 07, 2023	BUY	$132.51 - $164.9 $847,268 - $1.05 Million	6,394 Added 3.12%	211,651 $28.5 Million
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $6.04 Million - $6.96 Million	-41,770 Reduced 16.91%	205,257 $32.7 Million
Q4 2022 Jan 19, 2023	SELL	$138.31 - $165.87 $1.92 Million - $2.3 Million	-13,858 Reduced 5.31%	247,027 $0
Q3 2022 Oct 12, 2022	SELL	$134.21 - $153.93 $177,157 - $203,187	-1,320 Reduced 0.5%	260,885 $36.1 Million

Q2 2022 Jul 12, 2022	BUY	$137.62 - $174.96 $13.7 Million - $17.5 Million	99,768 Added 61.42%	262,205 $40.2 Million
Q1 2022 Apr 19, 2022	SELL	$131.98 - $163.75 $3.39 Million - $4.2 Million	-25,664 Reduced 13.64%	162,437 $28.1 Million
Q4 2021 Jan 26, 2022	SELL	$107.43 - $135.93 $519,209 - $656,949	-4,833 Reduced 2.51%	188,101 $25.5 Million
Q3 2021 Oct 18, 2021	BUY	$106.4 - $120.78 $20 Million - $22.7 Million	188,065 Added 3862.5%	192,934 $21.4 Million
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $80,170 - $89,314	762 Added 18.55%	4,869 $556,000
Q1 2021 Apr 19, 2021	BUY	$102.3 - $112.62 $141,480 - $155,753	1,383 Added 50.77%	4,107 $442,000
Q4 2020 Jan 25, 2021	SELL	$80.49 - $108.67 $38,635 - $52,161	-480 Reduced 14.98%	2,724 $292,000
Q3 2020 Oct 15, 2020	SELL	$85.91 - $100.83 $276,802 - $324,874	-3,222 Reduced 50.14%	3,204 $282,000
Q2 2020 Jul 13, 2020	SELL	$73.37 - $98.18 $3,154 - $4,221	-43 Reduced 0.66%	6,426 $637,000
Q1 2020 Apr 09, 2020	SELL	$64.5 - $97.79 $23.9 Million - $36.2 Million	-370,149 Reduced 98.28%	6,469 $493,000
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $26.7 Million - $33.4 Million	370,298 Added 5859.15%	376,618 $33.6 Million
Q3 2019 Oct 09, 2019	SELL	$62.98 - $75.72 $9,447 - $11,358	-150 Reduced 2.32%	6,320 $456,000
Q1 2019 Apr 09, 2019	BUY	$77.14 - $90.79 $7,714 - $9,079	100 Added 1.57%	6,470 $523,000
Q4 2018 Jan 17, 2019	BUY	$77.85 - $96.01 $31,451 - $38,788	404 Added 6.77%	6,370 $587,000
Q3 2018 Oct 19, 2018	BUY	$88.91 - $98.84 $506,431 - $562,992	5,696 Added 2109.63%	5,966 $564,000
Q2 2018 Jul 09, 2018	SELL	$89.78 - $106.23 $527,277 - $623,888	-5,873 Reduced 95.6%	270 $26,000
Q1 2018 Apr 09, 2018	BUY	$92.01 - $123.21 $565,217 - $756,879	6,143 New	6,143 $581,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polaris Wealth Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polaris Wealth Advisory Group, LLC with notifications on news.

Account

Polaris Wealth Advisory Group, LLC Abb Vie Inc. Transaction History